Americans continue to mourn the dozens of people who were killed and hundreds wounded by a crazed lunatic in Las Vegas on Sunday, and as is usually the case when guns are involved in a mass murder incident, the usual suspects are once more calling for gun bans.
As reported by Natural News founder/editor Mike Adams, the Health Ranger:
According to federal statistics, opioid prescription drugs killed 33,091 Americans in 2015 alone. Estimates put those numbers above 36,000 deaths for 2017.
The death toll at the Las Vegas Mandalay massacre was 59 (so far). Though a horrifying tragedy, opioid drugs alone are killing 560 times more people each year than died in the Vegas tragedy.
This means that opioid drugs alone are causing the near-equivalent of two Las Vegas massacres PER DAY in terms of the number killed.
That’s obscene. It’s criminal. But there are currently no calls at all to ban this highly dangerous, highly lethal class of drugs. Could it be because Big Pharma is such a big contributor to political campaigns?
According to the Center for Responsive Politics, which tracks industry donations to political parties and candidates, Big Pharma contributed nearly $60 million in 2016 alone. In the 2014 election cycle, the figure was nearly $30 million, and in 2012 — a presidential year — donations were nearly $50 million. So in just three election cycles, Big Pharma contributed somewhere in the neighborhood of $140 million to political action committees, individual politicians and other political organizations. It’s no wonder everyone on Capitol Hill is going soft on opioids.
In recent days, as reported by The National Sentinel, the Trump administration made some progress in curbing over-prescribing of opioids, which has been a major contributor to the epidemic. A presidential panel, the Commission on Combatting Drug Addition and Opioid Crisis headed by New Jersey Gov. Chris Christie, detailed new partnerships with researchers across academia, government, prescribers and patients to curb by half the amount of time needed to make available prescriptions that are not addictive.
“Over-prescribing can lead to excess pills falling into the wrong hands,” said PhRMA CEO Stephen J. Ubl. He added, “given the scope of this crisis, we believe it’s the right thing to do,” adding that it is “candidly an unprecedented step for the industry.”
His company will begin backing limits on opioid supplies to seven days rather than the traditional 30-day prescription cycle. And while that’s a good first step, it certainly isn’t a ban.
And no politician is calling for one, either, despite a mounting death toll that is so large it is overwhelming local medical examiners.